The article addresses the issue of pharmacological treatment of female urinary incontinence. It summarizes the two types of incontinence, i.e. stress urinary incontinence (SUI) and urgency incontinence, or even just urgency symptoms (overactive bladder – OAB). It focuses on the role of urethra in maintaining continence for women. The article covers new possibilities of pharmacological treatment of SUI with detailed analysis of the effects of a new drug - duloxetine (YENTREVE). In the second part, the article outlines the drugs most frequently used in the treatment of urgency incontinence or just urgency symptoms, mentioning new preparations and new forms of preparations already in use. It analyzes the effects of tolterodine (DETRUSITOL), oxybutinine (UROXAL) and solifenacine (VESICARE).

        Key words: female urinary incontinence, pharmacological treatment.